Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
ResMed | RMD | Nov 21, 2024 | 243.60 | +0.85 |
Resources Connection | RGP | Nov 21, 2024 | 8.40 | +1.33 |
Restaurant Brands International | QSR | Nov 21, 2024 | 69.78 | +0.53 |
Retail Bull 3X Direxion | RETL | Nov 21, 2024 | 9.69 | +5.10 |
Retail ETF Market Vectors | RTH | Nov 21, 2024 | 222.64 | +0.61 |
Retail Opportunity Investments | ROIC | Nov 21, 2024 | 17.38 | +0.06 |
ReTo Eco-Solutions | RETO | Nov 21, 2024 | 0.91 | +4.01 |
Retractable Technologies | RVP | Nov 21, 2024 | 0.60 | +1.91 |
REV Group | REVG | Nov 21, 2024 | 29.82 | +2.09 |
Revance Therapeutics | RVNC | Nov 21, 2024 | 3.84 | +1.05 |
Revelation Biosciences | REVB | Nov 21, 2024 | 0.75 | -0.76 |
Revenueshares Largecap | RWL | Nov 21, 2024 | 102.32 | +0.89 |
Revenueshares Midcap | RWK | Nov 21, 2024 | 122.19 | +1.80 |
Revenueshares Smallcap | RWJ | Nov 21, 2024 | 47.45 | +1.69 |
Revenueshares Ultra Dividend Fund | RDIV | Nov 21, 2024 | 51.73 | +1.22 |
Reviva Pharmaceuticals | RVPH | Nov 21, 2024 | 1.24 | +2.06 |
Revolution Medicines | RVMD | Nov 21, 2024 | 56.78 | -0.51 |
Revolve Group A | RVLV | Nov 21, 2024 | 34.82 | +3.08 |
Revvity | RVTY | Nov 21, 2024 | 111.11 | -0.21 |
REX American Resources | REX | Nov 21, 2024 | 45.54 | +1.65 |
Rexford Industrial Realty | REXR | Nov 21, 2024 | 41.97 | -1.66 |
Rexford Industrial Realty B Pref | REXR-B | Nov 21, 2024 | 22.99 | +0.39 |
Rexford Industrial Realty C Pref | REXR-C | Nov 21, 2024 | 22.80 | -2.36 |
Reynolds Consumer Products | REYN | Nov 21, 2024 | 27.61 | -0.11 |
Rezolute | RZLT | Nov 21, 2024 | 4.86 | -2.99 |
Rezolve AI Limited - Ordinary Shares | RZLV | Nov 21, 2024 | 1.74 | 0.00 |
RF Acquisition A | RFAC | Nov 21, 2024 | 11.46 | 0.00 |
RF Acquisition Corp II | RFAIU | Nov 21, 2024 | 10.26 | 0.00 |
RF Acquisition II | RFAI | Nov 21, 2024 | 10.20 | -0.05 |
RF Industries | RFIL | Nov 21, 2024 | 4.14 | +1.72 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.